Filter
5669
Filtered Results: 5669
Text search:
Rapid
Health
Assessment
Featured
Recommendations
594
New Publications
1570
Language
Document type
No document type
3158
Studies & Reports
914
Guidelines
811
Manuals
322
Strategic & Response Plan
226
Training Material
75
Fact sheets
74
Situation Updates
66
Resource Platforms
8
Infographics
8
Brochures
4
Online Courses
3
Countries / Regions
India
241
Global
221
Kenya
168
Ethiopia
133
Sierra Leone
120
Liberia
111
Western and Central Europe
110
South Africa
109
Myanmar / Burma
109
Uganda
105
Nepal
103
Nigeria
102
Bangladesh
84
Rwanda
83
Africa
82
Congo, Democratic Republic of
81
Indonesia
76
Syria
75
Malawi
73
Zambia
72
Tanzania
72
Ukraine
71
Ghana
65
Latin America and the Carribbean
63
Philippines
56
Namibia
48
South Sudan
46
Eastern Europe
41
Guinea
38
Mozambique
38
East and Southern Africa
38
West and Central Africa
37
Senegal
35
Zimbabwe
34
Cambodia
34
Asia
33
Russia
33
Brazil
32
Haiti
31
Lesotho
31
South–East Asia Region
31
Middle East and North Africa
29
Yemen
27
Pakistan
25
Burkina Faso
23
Afghanistan
22
Eastern Europe and Central Asia
20
Venezuela
19
Somalia
17
Jordan
17
Botswana
17
Madagascar
16
Cameroon
15
Germany
15
Sudan
14
Benin
14
Colombia
14
USA
13
Mali
12
Central African Republic
12
Eswatini/ Swaziland
12
Lebanon
11
Iraq
10
Thailand
10
Western Pacific Region
10
Tajikistan
10
Peru
9
Vietnam
9
Angola
8
Laos
8
Moldova
8
Turkey
7
Albania
7
Egypt
6
Argentina
6
Ecuador
6
Chile
6
Iran
6
Guinea-Bissau
5
Côte d’Ivoire / Ivory Coast
5
Niger
5
Chad
5
Libya
5
Sri Lanka
5
Italy
5
Georgia
5
Togo
4
China
4
Burundi
4
Mexico
4
Bhutan
4
Poland
4
Kazakhstan
4
Saudi Arabia
3
Gambia
3
Mauritania
3
Papua New Guinea
3
Dominican Republic
3
North Macedonia
3
Croatia
3
Honduras
3
El Salvador
3
Bolivia
3
Fiji
3
Palestine
3
Southern Africa
3
Timor Leste/ East Timor
3
Romania
3
Turkmenistan
3
Jamaica
3
France
3
Mauritius
3
Portugal
3
Spain
3
Morocco
2
Malaysia
2
Singapore
2
Serbia
2
Hungary
2
Greece
2
Paraguay
2
Djibouti
2
Armenia
2
Qatar
2
Bulgaria
2
Uzbekistan
2
Kyrgyzstan
2
North America
2
Tunisia
2
United Kingdom
2
Belarus
2
Ireland
1
Vanuatu
1
Cuba
1
Guatemala
1
Nicaragua
1
Other region
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Estonia
1
Lithuania
1
Slovakia
1
Uruguay
1
Japan
1
Denmark
1
Azerbaijan
1
Israel
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
2153
Clinical Guidelines
489
Key Resources
324
Public Health
284
Women & Child Health
259
Capacity Building
92
Pharmacy & Technologies
60
Annual Report MEDBOX
1
Toolboxes
COVID-19
627
HIV
416
TB
322
Mental Health
289
Rapid Response
242
Planetary Health
227
Ebola
226
Conflict
179
AMR
129
NTDs
127
Caregiver
124
Natural Hazards
121
Disability
108
NCDs
93
Refugee
92
Global Health Education
81
Pharmacy
78
Zika
56
Cholera
43
Polio
41
Health Financing Toolbox
40
Specific Hazards
35
Social Ethics
9
Typhoon
8
South Sudan
2
Health Financing
1
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
Diabetes mellitus (DM) is a global epidemic with significant morbidity. Diabetic
retinopathy (DR) is the specific microvascular complication of DM and affects 1 in 3 persons with DM. DR remains a leading cause of vision loss in working adult populations. Patients with severe levels of DR are report...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
Lymphatic filariasis (LF) is an avoidable, debilitating, disfiguring disease caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi and B. timori. Globally, 51.4 million people are
estimated to be infected. Lymphoedema and hydrocoele are the visible, chronic clinical co...
La filariose lymphatique (FL) est une maladie évitable, incapacitante et défigurante, due à une infestation par des filaires parasites des espèces Wuchereria bancrofti, Brugia malayi et B. timori. On estime que 51,4 millions de personnes sont infectées dans le monde. Le lymphœdème et l’hydr...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international ...
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u...
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health<...
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document ...
The cholera outbreak has affected 14 countries in the WHO African Region. The climate-induced natural disasters such as cyclone and flooding in the southern African region and drought in the Horn of Africa led to increase in cases of cholera in many of the affected countries. With the rainy season c...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental health treatments and progressi...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment cri...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
HIV testing programmes need to ensure that all clients who test for HIV are provided with correct diagnoses. The accuracy of HIV testing is critical to prevent misdiagnosis, as the consequences of giving an incorrect test result can be serious for clients, HIV testing services, HIV programmes and pu...
